The first study involving the role of TGF-β in the development of CD was carried out in 1991, observing that, when peritoneal macrophages from mice and humans were treated with TGF-β, the trypanocide capacity of IFN-γ was inhibited (Silva et al., 1991). The gene discussed is TGFB1; the disease is Cowden disease.